2015
Breast Cancer Screening in the Setting of Dense Breast Tissue
Freund KM, Bates CK, Henrich JB. Breast Cancer Screening in the Setting of Dense Breast Tissue. Journal Of Women's Health 2015, 24: 855-857. PMID: 26484780, DOI: 10.1089/jwh.2015.5405.Peer-Reviewed Original Research
1999
Postmenopausal Estrogen Replacement Therapy Is Associated with Adverse Breast Cancer Prognostic Indices
LeBlanc ES, Viscoli CM, Henrich JB. Postmenopausal Estrogen Replacement Therapy Is Associated with Adverse Breast Cancer Prognostic Indices. Journal Of Women's Health 1999, 8: 815-823. PMID: 10495262, DOI: 10.1089/152460999319138.Peer-Reviewed Original ResearchConceptsEstrogen replacement therapyPrognostic indexERT usersTumor characteristicsPrognostic groupsReplacement therapyOdds ratioUsers of ERTPostmenopausal estrogen replacement therapyNegative estrogen receptor statusBiopsy-proven breast cancerFavorable tumor characteristicsBreast cancer patientsEstrogen receptor statusLong-term outcomesPoor prognostic groupTime of mammographyEarly-stage tumorsAdverse prognostic indexSelf-administered questionnairePositive nodesPostmenopausal womenERT useReceptor statusCancer patients
1998
Postmenopausal Estrogen Use and Invasive versus in situ Breast Cancer Risk
Henrich J, Kornguth P, Viscoli C, Horwitz R. Postmenopausal Estrogen Use and Invasive versus in situ Breast Cancer Risk. Journal Of Clinical Epidemiology 1998, 51: 1277-1283. PMID: 10086820, DOI: 10.1016/s0895-4356(98)00116-4.Peer-Reviewed Original ResearchConceptsBreast cancer riskInvasive breast cancerOverall odds ratioERT useBreast cancerCancer riskEstrogen replacement therapy usePostmenopausal women 45 yearsSitu breast cancer riskPostmenopausal estrogen useSitu breast cancerWomen 45 yearsCase-control studyLack of associationDistinct biological differencesEstrogen useTherapy useSitu diseaseInvasive diseaseOdds ratioInvasive tumorsRisk estimatesSmall sample sizeCancerPositive association